is tirzepatide still available compounded FDA ban on tirzepatide: Switch to name brand medications sustainable wellness goals. Compounded Tirzepatide GLP-1 Weight Loss
Description
One of the promising advancements in this area is Tirzepatide, a medication initially developed for type 2 diabetes, now being explored for its potential in weight management due to its dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist properties
Food and Drug Administration (FDA), compounded medications are not approved by the FDA for quality, safety, or effectiveness
PlexusDx provides access to compounded tirzepatide injections starting at $249 per month, with personalized dosing guidance tailored to your health profile
Semaglutide is the first GLP-1 therapy to win approval for obesity
2024;22:1999-2010.e8
